209 related articles for article (PubMed ID: 17291937)
1. Selective clearance of macrophages in atherosclerotic plaques by autophagy.
Verheye S; Martinet W; Kockx MM; Knaapen MW; Salu K; Timmermans JP; Ellis JT; Kilpatrick DL; De Meyer GR
J Am Coll Cardiol; 2007 Feb; 49(6):706-15. PubMed ID: 17291937
[TBL] [Abstract][Full Text] [Related]
2. Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy.
Martinet W; Verheye S; De Meyer GR
Autophagy; 2007; 3(3):241-4. PubMed ID: 17224626
[TBL] [Abstract][Full Text] [Related]
3. Selective clearance of macrophages in atherosclerotic plaques by the protein synthesis inhibitor cycloheximide.
Croons V; Martinet W; Herman AG; Timmermans JP; De Meyer GR
J Pharmacol Exp Ther; 2007 Mar; 320(3):986-93. PubMed ID: 17135342
[TBL] [Abstract][Full Text] [Related]
4. Everolimus triggers cytokine release by macrophages: rationale for stents eluting everolimus and a glucocorticoid.
Martinet W; Verheye S; De Meyer I; Timmermans JP; Schrijvers DM; Van Brussel I; Bult H; De Meyer GR
Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1228-35. PubMed ID: 22345170
[TBL] [Abstract][Full Text] [Related]
5. Everolimus inhibits monocyte/macrophage migration in vitro and their accumulation in carotid lesions of cholesterol-fed rabbits.
Baetta R; Granata A; Canavesi M; Ferri N; Arnaboldi L; Bellosta S; Pfister P; Corsini A
J Pharmacol Exp Ther; 2009 Feb; 328(2):419-25. PubMed ID: 19023042
[TBL] [Abstract][Full Text] [Related]
6. Macrophages but not smooth muscle cells undergo benzyloxycarbonyl-Val-Ala-DL-Asp(O-Methyl)-fluoromethylketone-induced nonapoptotic cell death depending on receptor-interacting protein 1 expression: implications for the stabilization of macrophage-rich atherosclerotic plaques.
Martinet W; De Meyer GR; Timmermans JP; Herman AG; Kockx MM
J Pharmacol Exp Ther; 2006 Jun; 317(3):1356-64. PubMed ID: 16537794
[TBL] [Abstract][Full Text] [Related]
7. Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.
Iwamaru A; Kondo Y; Iwado E; Aoki H; Fujiwara K; Yokoyama T; Mills GB; Kondo S
Oncogene; 2007 Mar; 26(13):1840-51. PubMed ID: 17001313
[TBL] [Abstract][Full Text] [Related]
8. Everolimus, a promising medical therapy for coronary heart disease?
Jia L; Hui RT
Med Hypotheses; 2009 Aug; 73(2):153-5. PubMed ID: 19375241
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of mTOR by lentivirus‑mediated RNA interference suppresses atherosclerosis and stabilizes plaques via a decrease of macrophages by autophagy in apolipoprotein E‑deficient mice.
Wang X; Li L; Li M; Dang X; Wan L; Wang N; Bi X; Gu C; Qiu S; Niu X; Zhu X; Wang L
Int J Mol Med; 2013 Nov; 32(5):1215-21. PubMed ID: 24043133
[TBL] [Abstract][Full Text] [Related]
10. mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques.
Martinet W; De Loof H; De Meyer GRY
Atherosclerosis; 2014 Apr; 233(2):601-607. PubMed ID: 24534455
[TBL] [Abstract][Full Text] [Related]
11. Effect of statins on the viability of macrophages and smooth muscle cells.
Croons V; De Meyer I; Houten SM; Martinet W; Bult H; Herman AG; De Meyer GR
J Cardiovasc Pharmacol; 2010 Mar; 55(3):269-75. PubMed ID: 20051876
[TBL] [Abstract][Full Text] [Related]
12. Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia.
Mueller MA; Beutner F; Teupser D; Ceglarek U; Thiery J
Atherosclerosis; 2008 May; 198(1):39-48. PubMed ID: 17980369
[TBL] [Abstract][Full Text] [Related]
13. Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injury.
Nakagawa S; Nishihara K; Inui K; Masuda S
Eur J Pharmacol; 2012 Dec; 696(1-3):143-54. PubMed ID: 23022334
[TBL] [Abstract][Full Text] [Related]
14. Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability.
Schrijvers DM; De Meyer GR; Herman AG; Martinet W
Cardiovasc Res; 2007 Feb; 73(3):470-80. PubMed ID: 17084825
[TBL] [Abstract][Full Text] [Related]
15. IGF-I, EGF, and sex steroids regulate autophagy in bovine mammary epithelial cells via the mTOR pathway.
Sobolewska A; Gajewska M; Zarzyńska J; Gajkowska B; Motyl T
Eur J Cell Biol; 2009 Feb; 88(2):117-30. PubMed ID: 19013662
[TBL] [Abstract][Full Text] [Related]
16. Selective depletion of macrophages in atherosclerotic plaques via macrophage-specific initiation of cell death.
Martinet W; Verheye S; De Meyer GR
Trends Cardiovasc Med; 2007 Feb; 17(2):69-75. PubMed ID: 17292050
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced macrophage autophagy in atherosclerosis: for better or worse?
Martinet W; De Meyer I; Verheye S; Schrijvers DM; Timmermans JP; De Meyer GR
Basic Res Cardiol; 2013 Jan; 108(1):321. PubMed ID: 23233268
[TBL] [Abstract][Full Text] [Related]
19. Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma.
Yazbeck VY; Buglio D; Georgakis GV; Li Y; Iwado E; Romaguera JE; Kondo S; Younes A
Exp Hematol; 2008 Apr; 36(4):443-50. PubMed ID: 18343280
[TBL] [Abstract][Full Text] [Related]
20. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
